Bausch Health Cos Inventory Turnover Ratio 2010-2023 | BHC

Bausch Health Cos inventory turnover ratio from 2010 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Bausch Health Cos Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.143B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.328B 5.17
Dr Reddy's Laboratories (RDY) India $11.833B 18.71
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.387B 0.00
Amphastar Pharmaceuticals (AMPH) United States $1.889B 12.93
Supernus Pharmaceuticals (SUPN) United States $1.580B 0.00
Taysha Gene Therapies (TSHA) United States $0.451B 0.00
Generation Bio (GBIO) United States $0.185B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.029B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00